Literature DB >> 9629843

Cyclooxygenase-2 is induced globally in infarcted human brain.

T Sairanen1, A Ristimäki, M L Karjalainen-Lindsberg, A Paetau, M Kaste, P J Lindsberg.   

Abstract

Cyclooxygenase (COX) catalyzes synthesis of prostanoids after liberation of arachidonic acid, an important biochemical sequela of cerebral ischemia that aggravates brain injury. We investigated expression of inducible COX-2 in infarcted human brains (symptom duration, 15 hours to 18 days) and found that COX-2 protein was present in both neuronal and glial cells throughout the brain in accord with infarct topography and duration. These results emphasize the global yet temporally regulated nature of COX-2 induction during focal ischemia in humans, clearly different from the circumscribed acute expression reported in experimental animal models. We speculate that early induction of COX-2 may fuel tissue damage through prostanoids and free radicals, and delayed induction in remote brain areas may promote reconstitutive processes in the face of tissue scarring and remodeling of the surviving neural networks.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9629843     DOI: 10.1002/ana.410430608

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  30 in total

Review 1.  The inflammatory response in stroke.

Authors:  Qing Wang; Xian Nan Tang; Midori A Yenari
Journal:  J Neuroimmunol       Date:  2006-12-26       Impact factor: 3.478

Review 2.  Inflammatory responses in brain ischemia.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

3.  Inflammation after stroke: mechanisms and therapeutic approaches.

Authors:  Muzamil Ahmad; Steven H Graham
Journal:  Transl Stroke Res       Date:  2010-06       Impact factor: 6.829

4.  Prostacyclin receptor deletion aggravates hippocampal neuronal loss after bilateral common carotid artery occlusion in mouse.

Authors:  G Wei; K K Kibler; R C Koehler; T Maruyama; S Narumiya; S Doré
Journal:  Neuroscience       Date:  2008-08-20       Impact factor: 3.590

5.  Prokineticin 2 is an endangering mediator of cerebral ischemic injury.

Authors:  Michelle Y Cheng; Alex G Lee; Collin Culbertson; Guohua Sun; Rushi K Talati; Nathan C Manley; Xiaohan Li; Heng Zhao; David M Lyons; Qun-Yong Zhou; Gary K Steinberg; Robert M Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

6.  Dual inhibition of cyclooxygenase and lipoxygenase enzymes by human cerebrospinal fluid.

Authors:  Sheikh Arshad Saeed; Kaneez Fatima Shad; Shabana Usman Simjee
Journal:  Exp Brain Res       Date:  2007-03-20       Impact factor: 1.972

7.  Tenoxicam exerts a neuroprotective action after cerebral ischemia in rats.

Authors:  Rita I M Galvão; João P L Diógenes; Graziela C L Maia; Emídio A S Filho; Silvânia M M Vasconcelos; Dalgimar B de Menezes; Geanne M A Cunha; Glauce S B Viana
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

8.  Cyclooxygenase-2 expression in astrocytes and microglia in human oligodendroglioma and astrocytoma.

Authors:  S G Temel; Z Kahveci
Journal:  J Mol Histol       Date:  2010-01-06       Impact factor: 2.611

9.  Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controls.

Authors:  Koyi Choi; Hean Zhuang; Barbara Crain; Sylvain Doré
Journal:  J Neuroimmunol       Date:  2008-03-18       Impact factor: 3.478

Review 10.  Pathophysiological Roles of Cyclooxygenases and Prostaglandins in the Central Nervous System.

Authors:  Tatsurou Yagami; Hiromi Koma; Yasuhiro Yamamoto
Journal:  Mol Neurobiol       Date:  2015-09-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.